Last updated on June 2019

A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease


Brief description of study

This is a Phase 3, randomized, double-blind, placebo-controlled study to demonstrate the effect of oral ozanimod as maintenance therapy in subjects with moderately to severely active Crohn's Disease.

Clinical Study Identifier: NCT03464097

Find a site near you

Start Over

Emmed Research

Pretoria, South Africa
6.47miles
  Connect »